Changzhou Pharmaceutical Factory, based in China, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their notable products is EZETIMIBE (ROUTE CODE: ZT), with a corresponding US DMF Number 35963.
Remarkably, this DMF maintains an Active status since its submission on May 27, 2021, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of July 03, 2023, and payment made on May 18, 2023, indicating their dedication to facilitating drug approvals, Categorized as Type II